Spruce Biosciences

-$0.03 (-2.27%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRB and other ETFs, options, and stocks.

About SPRB

Spruce Biosciences, Inc operates as a late-stage biopharmaceutical company, which focuses on the development of novel therapies for rare diseases affecting the endocrine system. The firm is initially developing its wholly-owned product candidate, tildacerfont, as the non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia.

CEO
Javier Szwarcberg
Employees
15
Headquarters
Daly City, California
Founded
2014

SPRB Key Statistics

Market cap
30.99M
Price-Earnings ratio
—
Dividend yield
—
Average volume
105.12K
High today
$1.46
Low today
$1.25
Open price
$1.46
Volume
119.48K
52 Week high
$15.08
52 Week low
$1.25

SPRB Earnings

-$12.35
-$8.23
-$4.12
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.46 per share
Actual
-$0.50 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure